亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

NATURal history of coronary PlaquE on cardiac computed tomography in individuals without MACE or lipid-lowering therapy: NATURE-CTstudy

医学 狼牙棒 心脏病学 冠状动脉疾病 内科学 狭窄 人口 心脏成像 放射科 队列 计算机断层血管造影 临床终点 自然史 肾脏疾病 冠状动脉钙 血管造影 冠状动脉粥样硬化 糖尿病 易损斑块 无症状的 前瞻性队列研究 队列研究 冠状动脉钙评分 射血分数 试验预测值 自然史研究
作者
Jairo Aldana-Bitar,Srikanth Krishnan,Keishi Ichikawa,April Kinninger,Logan C Hubbard,Tamer Sallam,Sion Roy,Suvasini Lakshmanan,Matthew Jay Budoff,Ronald P. Karlsberg
出处
期刊:Journal of Cardiovascular Computed Tomography [Elsevier BV]
卷期号:20 (4): 375-381
标识
DOI:10.1016/j.jcct.2026.05.002
摘要

Background Coronary artery disease (CAD) progression has been examined mainly in cohorts enriched for major adverse cardiovascular events (MACE), a high burden of traditional risk factors, or prior exposure to risk-modifying therapies. In contrast, plaque progression is poorly described in patients without prior MACE and receiving no anti-atherosclerotic treatment who undergo cardiac computed tomography angiography (CCTA) for clinical indications. We therefore investigated atherosclerosis progression in this understudied population using serial CCTA. Methods The NATURE-CT study retrospectively identified 205 participants from two outpatient cardiovascular imaging centers in Los Angeles. Eligible participants had ​≥ ​two clinically indicated CCTAs at least 24 months apart, had a baseline coronary artery calcium score (CAC) ​≤ ​100, and experienced no interim MACE. Use of lipid-lowering or other anti-atherosclerotic medications was absent between scans. Individuals with diabetes mellitus, familial hypercholesterolemia, or chronic kidney disease were excluded. Plaque volume and luminal stenosis on each scan were quantified with a validated artificial-intelligence quantitative CT platform (AI-QCT; Cleerly Labs). The primary endpoint was the annualized change in total plaque volume (mm 3 per year). Results The cohort had a mean age of 54.9 ​± ​10.2 years and 72% were White men; 24 % had hypertension, 28 % dyslipidemia, and 15 % were current or former smokers. Mean baseline LDL was 111.6 ​± ​32.0 ​mg/dL. The median time between CCTA scans was 4.9 ​± ​2.2 years. At baseline, 54% had a CAC ​= ​0. Median non-calcified plaque volumes increased from 27.5 ​mm 3 [interquartile range [IQR]: 10.1–55.5] to 53.5 ​mm 3 [24.0–97.9], with an annualized change of 4.9 ​mm 3 /year [1.4–9.6]. Calcified plaque volume increased from 0.3 ​mm 3 [0.0–5.7] to 3.2 ​mm 3 [0.1–18.2], with an annualized change of 0.4 ​mm 3 /year [0.0–2.4]. Low attenuation plaque (LAP) was present in 9% at baseline, and 23% at follow-up. Rapid plaque progression (annual percent atheroma volume (PAV) ​≥ ​1 % per PARADIGM) occurred in 6 participants (3 %), while 23 participants (11 %) exhibited an annual PAV increase ≥0.59 % (PARADIGM-derived intermediate threshold). Conclusion Over a median 5-year interval, atherosclerotic burden increased even in patients with minimal baseline CAC, no prior MACE, and no lipid-lowering therapy. Non-calcified plaque accumulated faster than calcified plaque. While rare in healthy individuals, LAP became more prevalent, and a small subset experienced rapid plaque progression.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
沉默的涔完成签到 ,获得积分10
2秒前
Ava的应助被儒雅傲人采纳,获得10
3秒前
CipherSage的应助被儒雅傲人采纳,获得10
3秒前
慕青的应助被儒雅傲人采纳,获得10
3秒前
大个的应助被儒雅傲人采纳,获得10
3秒前
CipherSage的应助被儒雅傲人采纳,获得10
3秒前
Jasper的应助被儒雅傲人采纳,获得10
3秒前
科研通AI6.3的应助被儒雅傲人采纳,获得10
3秒前
小蘑菇的应助被儒雅傲人采纳,获得10
3秒前
molihuakai的应助被儒雅傲人采纳,获得10
3秒前
Maestro_S的应助被儒雅傲人采纳,获得30
4秒前
8秒前
干净的中心完成签到,获得积分10
8秒前
星辰大海的应助被儒雅傲人采纳,获得10
9秒前
CipherSage的应助被儒雅傲人采纳,获得10
9秒前
华仔的应助被儒雅傲人采纳,获得10
10秒前
充电宝的应助被儒雅傲人采纳,获得10
10秒前
天天快乐的应助被儒雅傲人采纳,获得10
10秒前
Crssss的应助被儒雅傲人采纳,获得10
10秒前
Lucas的应助被儒雅傲人采纳,获得20
11秒前
完美世界的应助被儒雅傲人采纳,获得10
11秒前
小二郎的应助被儒雅傲人采纳,获得10
11秒前
11秒前
忧虑的元正完成签到,获得积分10
14秒前
科目三的应助被儒雅傲人采纳,获得10
16秒前
田様的应助被儒雅傲人采纳,获得10
16秒前
传奇3的应助被儒雅傲人采纳,获得10
16秒前
在水一方的应助被儒雅傲人采纳,获得30
16秒前
想退休的快乐土豆泥完成签到,获得积分10
17秒前
酷波er的应助被儒雅傲人采纳,获得10
17秒前
科研通AI6.4的应助被儒雅傲人采纳,获得10
17秒前
充电宝的应助被儒雅傲人采纳,获得10
17秒前
17秒前
科研通AI6.2的应助被儒雅傲人采纳,获得10
17秒前
科研通AI65的应助被儒雅傲人采纳,获得10
17秒前
JamesPei的应助被儒雅傲人采纳,获得30
17秒前
经十路以东完成签到,获得积分10
19秒前
浅荫发布了新的文献求助10
21秒前
休斯顿完成签到,获得积分10
22秒前
朴素的敏完成签到 ,获得积分10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172954
求助须知:如何正确求助?哪些是违规求助? 9565479
关于积分的说明 21780029
捐赠科研通 7764837
什么是DOI,文献DOI怎么找? 3431499
关于科研通互助平台的介绍 2555519
邀请新用户注册赠送积分活动 2476579